AKT1 and prostate carcinoma: In prostate cancer patients, increased epithelial levels of phosphorylated EGF-receptor and phosphorylated AKT in the benign tinted prostate epithelium were associated with raised epithelial cell proliferation, high disease aggressiveness and poor patient outcome53,54.